Effect of inhibition of multiple steps of angiogenesis in syngeneic murine pleural mesothelioma

Robert E. Merritt, Reiko E. Yamada, Nabil Wasif, Ronald Crystal, Robert J. Korst

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Background Angiogenesis is a multistep process in which the endothelial cell plays a pivotal role. We hypothesized that the combination of two antiangiogenic agents with distinct mechanisms of action would more effectively inhibit tumor growth than either agent alone in a murine mesothelioma model. Methods A syngeneic murine mesothelioma flank tumor model (AB-12) was established in BALB/c mice. Separate adenovirus vectors expressing the cDNAs for human pigment epithelium-derived factor (AdPEDF) and a soluble form of the human vascular endothelial growth factor receptor-1 (Adsflt-1) were administered intratumorally. End points measured included tumor size, animal survival, and microvessel density using CD31 immunohistochemistry. An orthotopic model of mesothelioma was established by implanting AB-12 cells into the murine pleural cavity. Simultaneously, AdPEDF and Adsflt-1 were instilled intrapleurally and tumor burden and survival were recorded. The development of pulmonary emphysema was also assessed by calculating the mean linear intercept (a measure of interalveolar septal distance) in histologic lung sections from tumor-free mice after vector administration. Results In the flank tumor model, the combination of AdPEDF and Adsflt-1 inhibited tumor growth, prolonged survival, and decreased microvessel density more profoundly compared with either AdPEDF or Adsflt-1 alone. In the orthotopic model, the combination was also more effective in prolonging survival. Intrapleural AdPEDF or Adsflt-1 did not increase the mean linear intercept compared with controls in tumor-free mice. Conclusions In this murine model, inhibiting multiple mechanisms of angiogenesis using two agents is a more effective antineoplastic strategy than using either agent alone. In addition, instillation of antiangiogenic gene transfer vectors into the pleural space does not result in histologic evidence of pulmonary emphysema.

Original languageEnglish
Pages (from-to)1042-1051
Number of pages10
JournalAnnals of Thoracic Surgery
Volume78
Issue number3
DOIs
Publication statusPublished - 1 Sep 2004
Externally publishedYes

Fingerprint

Mesothelioma
Neoplasms
Pulmonary Emphysema
Microvessels
Survival
Pleural Cavity
Angiogenesis Inhibitors
Growth
Tumor Burden
Adenoviridae
Antineoplastic Agents
Endothelial Cells
Complementary DNA
Immunohistochemistry
Lung
Genes

Keywords

  • 14

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Surgery

Cite this

Effect of inhibition of multiple steps of angiogenesis in syngeneic murine pleural mesothelioma. / Merritt, Robert E.; Yamada, Reiko E.; Wasif, Nabil; Crystal, Ronald; Korst, Robert J.

In: Annals of Thoracic Surgery, Vol. 78, No. 3, 01.09.2004, p. 1042-1051.

Research output: Contribution to journalArticle

Merritt, Robert E. ; Yamada, Reiko E. ; Wasif, Nabil ; Crystal, Ronald ; Korst, Robert J. / Effect of inhibition of multiple steps of angiogenesis in syngeneic murine pleural mesothelioma. In: Annals of Thoracic Surgery. 2004 ; Vol. 78, No. 3. pp. 1042-1051.
@article{4e7acf7a3d73471b91175a38ca95a351,
title = "Effect of inhibition of multiple steps of angiogenesis in syngeneic murine pleural mesothelioma",
abstract = "Background Angiogenesis is a multistep process in which the endothelial cell plays a pivotal role. We hypothesized that the combination of two antiangiogenic agents with distinct mechanisms of action would more effectively inhibit tumor growth than either agent alone in a murine mesothelioma model. Methods A syngeneic murine mesothelioma flank tumor model (AB-12) was established in BALB/c mice. Separate adenovirus vectors expressing the cDNAs for human pigment epithelium-derived factor (AdPEDF) and a soluble form of the human vascular endothelial growth factor receptor-1 (Adsflt-1) were administered intratumorally. End points measured included tumor size, animal survival, and microvessel density using CD31 immunohistochemistry. An orthotopic model of mesothelioma was established by implanting AB-12 cells into the murine pleural cavity. Simultaneously, AdPEDF and Adsflt-1 were instilled intrapleurally and tumor burden and survival were recorded. The development of pulmonary emphysema was also assessed by calculating the mean linear intercept (a measure of interalveolar septal distance) in histologic lung sections from tumor-free mice after vector administration. Results In the flank tumor model, the combination of AdPEDF and Adsflt-1 inhibited tumor growth, prolonged survival, and decreased microvessel density more profoundly compared with either AdPEDF or Adsflt-1 alone. In the orthotopic model, the combination was also more effective in prolonging survival. Intrapleural AdPEDF or Adsflt-1 did not increase the mean linear intercept compared with controls in tumor-free mice. Conclusions In this murine model, inhibiting multiple mechanisms of angiogenesis using two agents is a more effective antineoplastic strategy than using either agent alone. In addition, instillation of antiangiogenic gene transfer vectors into the pleural space does not result in histologic evidence of pulmonary emphysema.",
keywords = "14",
author = "Merritt, {Robert E.} and Yamada, {Reiko E.} and Nabil Wasif and Ronald Crystal and Korst, {Robert J.}",
year = "2004",
month = "9",
day = "1",
doi = "10.1016/j.athoracsur.2004.03.021",
language = "English",
volume = "78",
pages = "1042--1051",
journal = "Annals of Thoracic Surgery",
issn = "0003-4975",
publisher = "Elsevier USA",
number = "3",

}

TY - JOUR

T1 - Effect of inhibition of multiple steps of angiogenesis in syngeneic murine pleural mesothelioma

AU - Merritt, Robert E.

AU - Yamada, Reiko E.

AU - Wasif, Nabil

AU - Crystal, Ronald

AU - Korst, Robert J.

PY - 2004/9/1

Y1 - 2004/9/1

N2 - Background Angiogenesis is a multistep process in which the endothelial cell plays a pivotal role. We hypothesized that the combination of two antiangiogenic agents with distinct mechanisms of action would more effectively inhibit tumor growth than either agent alone in a murine mesothelioma model. Methods A syngeneic murine mesothelioma flank tumor model (AB-12) was established in BALB/c mice. Separate adenovirus vectors expressing the cDNAs for human pigment epithelium-derived factor (AdPEDF) and a soluble form of the human vascular endothelial growth factor receptor-1 (Adsflt-1) were administered intratumorally. End points measured included tumor size, animal survival, and microvessel density using CD31 immunohistochemistry. An orthotopic model of mesothelioma was established by implanting AB-12 cells into the murine pleural cavity. Simultaneously, AdPEDF and Adsflt-1 were instilled intrapleurally and tumor burden and survival were recorded. The development of pulmonary emphysema was also assessed by calculating the mean linear intercept (a measure of interalveolar septal distance) in histologic lung sections from tumor-free mice after vector administration. Results In the flank tumor model, the combination of AdPEDF and Adsflt-1 inhibited tumor growth, prolonged survival, and decreased microvessel density more profoundly compared with either AdPEDF or Adsflt-1 alone. In the orthotopic model, the combination was also more effective in prolonging survival. Intrapleural AdPEDF or Adsflt-1 did not increase the mean linear intercept compared with controls in tumor-free mice. Conclusions In this murine model, inhibiting multiple mechanisms of angiogenesis using two agents is a more effective antineoplastic strategy than using either agent alone. In addition, instillation of antiangiogenic gene transfer vectors into the pleural space does not result in histologic evidence of pulmonary emphysema.

AB - Background Angiogenesis is a multistep process in which the endothelial cell plays a pivotal role. We hypothesized that the combination of two antiangiogenic agents with distinct mechanisms of action would more effectively inhibit tumor growth than either agent alone in a murine mesothelioma model. Methods A syngeneic murine mesothelioma flank tumor model (AB-12) was established in BALB/c mice. Separate adenovirus vectors expressing the cDNAs for human pigment epithelium-derived factor (AdPEDF) and a soluble form of the human vascular endothelial growth factor receptor-1 (Adsflt-1) were administered intratumorally. End points measured included tumor size, animal survival, and microvessel density using CD31 immunohistochemistry. An orthotopic model of mesothelioma was established by implanting AB-12 cells into the murine pleural cavity. Simultaneously, AdPEDF and Adsflt-1 were instilled intrapleurally and tumor burden and survival were recorded. The development of pulmonary emphysema was also assessed by calculating the mean linear intercept (a measure of interalveolar septal distance) in histologic lung sections from tumor-free mice after vector administration. Results In the flank tumor model, the combination of AdPEDF and Adsflt-1 inhibited tumor growth, prolonged survival, and decreased microvessel density more profoundly compared with either AdPEDF or Adsflt-1 alone. In the orthotopic model, the combination was also more effective in prolonging survival. Intrapleural AdPEDF or Adsflt-1 did not increase the mean linear intercept compared with controls in tumor-free mice. Conclusions In this murine model, inhibiting multiple mechanisms of angiogenesis using two agents is a more effective antineoplastic strategy than using either agent alone. In addition, instillation of antiangiogenic gene transfer vectors into the pleural space does not result in histologic evidence of pulmonary emphysema.

KW - 14

UR - http://www.scopus.com/inward/record.url?scp=4444325749&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4444325749&partnerID=8YFLogxK

U2 - 10.1016/j.athoracsur.2004.03.021

DO - 10.1016/j.athoracsur.2004.03.021

M3 - Article

C2 - 15337045

AN - SCOPUS:4444325749

VL - 78

SP - 1042

EP - 1051

JO - Annals of Thoracic Surgery

JF - Annals of Thoracic Surgery

SN - 0003-4975

IS - 3

ER -